(Q36157458)

English

Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

0 references

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

systematic review

1 reference

based on heuristic

inferred from title

frontotemporal lobar degeneration

1 reference

based on heuristic

inferred from title

Lars-Olof Wahlund

5

object named as

Lars-Olof Wahlund

0 references

4

object named as

Eric Westman

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

author name string

Amado Rivero-Santana

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Daniel Ferreira

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Lilisbeth Perestelo-Pérez

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Antonio Sarría

6

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Pedro Serrano-Aguilar

7

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

publication date

4 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

625-644

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Prevalence of dementia subtypes: a 30-year retrospective survey of neuropathological reports

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

The epidemiology of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Neuropathological background of phenotypical variability in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Fronto-temporal dementia: nosology, neuropsychology, and neuropathology

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Classification of primary progressive aphasia and its variants

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Pathologically proven frontotemporal dementia presenting with severe amnesia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

The evolution and pathology of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Clinical and psychometric distinction of frontotemporal and Alzheimer dementias

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Variability in cognitive presentation of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF biomarkers in frontotemporal lobar degeneration with known pathology

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF neurofilament proteins in the differential diagnosis of dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF biomarkers for Alzheimer's disease: current utility and potential future use.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Disentangling normal aging from Alzheimer's disease in structural magnetic resonance images

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF biomarker levels in early and late onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Frontotemporal lobar degeneration: clinical and pathological relationships

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Antemortem diagnosis of frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Frontotemporal dementia: clinicopathological correlations

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

CSF markers for incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Clinical staging and disease progression in frontotemporal dementia.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160366

21 January 2018

Identifiers

10.3233/JAD-160366

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36157458&oldid=1619192357"